MARY GRAVES: Open Payments
NPI 1336562743 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 44 payments from 13 companies in 2025. Trend: 2023 $922 · 2024 $1,009 · 2025 $938
Food & beverage: $872Education: $66
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $233 |
| Janssen Biotech, Inc. | 8 | $201 |
| Regeneron Healthcare Solutions, Inc. | 4 | $107 |
| GENZYME CORPORATION | 4 | $87 |
| ConvaTec Inc. | 2 | $56 |
| ABBVIE INC. | 2 | $46 |
| Amgen Inc. | 2 | $45 |
| Incyte Corporation | 2 | $43 |
| UCB, Inc. | 2 | $42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
Products named: TREMFYA, DUPIXENT, COSENTYX, INNOVAMATRIX AC, Rhapsido, RINVOQ, OTEZLA, OPZELURA.
Industry payments across VA — which companies pay providers there.
